Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Antabio bolsters leadership team

The French biopharma appoints four new executives

- PMLiVE

The power of pharma businesses to drive social change

The importance of CSR programmes

Through the Looking Glass

Non-traditional innovation

- PMLiVE

How to measure marketing success: profit vs ROI

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and...

Blue Latitude Health

Roche Basel Switzerland

Roche’s Ocrevus is first primary progressive MS drug in EU

Analysts predict the drug could be a $3bn product by 2021

- PMLiVE

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

Further evidence is required to warrant approval according to the US regulator

- PMLiVE

Ferring agrees Chinese reproductive medicine research deal

Work with the Chinese Academy of Sciences on the long-term project

- PMLiVE

Healthcare Communications agency F/NE joins GLOBALHealthPR’s network

The South-African agency has a presence in over 40 other countries

- PMLiVE

Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

She succeeds Bruno Strigini who retires

Four ways technology will make your exhibition stand more successful

Apex Events and Exhibitions

Transforming access in rare diseases

A quiet revolution is underway that could transform access to medicines in rare diseases, according to Duchenne UK, the charity at the heart of a new project to streamline evidence-gathering...

AstraZeneca AZ

AZ gets EMA green light for severe asthma drug Fasenra

The biologic respiratory treatment will go up against GSK’s Nucala and Teva’s Cinqaero

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links